Antimicrobial Resistance (AMR) is a posh international well being problem, with vital implications for human well being, social well-being, and financial improvement.
On 6 September 2022, WHO will maintain a high-level webinar to launch and share the findings of the International Proof Evaluate on Well being and Migration (GEHM) with a give attention to AMR. The report, the fourth of the GEHM sequence, explores proof on entry and use of important antimicrobials in worldwide migrant and refugee populations and gives coverage concerns to help policymakers in addressing nationwide and international challenges associated to AMR and migration.
Launched on 17 June 2021, the GEHM sequence is an evidence-informed normative product to reply to coverage questions on migration-related public well being priorities. The GEHM sequence additionally addresses data gaps and proposes coverage concerns on the well being standing and well being insurance policies associated to refugees and migrants by summarizing the perfect obtainable proof worldwide.
The upcoming GEHM on AMR is the results of the interdivisional collaboration between WHO’s Well being and Migration Programme (PHM), the Division of Surveillance, Prevention and Management (SPC) of the Antimicrobial Resistance Division (AMR), and the International Technique Lab at York College – the WHO Collaborating Centre on International Governance of Antimicrobial resistance. PHM and SPC/AMR departments partnered with WHO Regional Workplaces, the Worldwide Group for Migration (IOM), the Workplace of the United Nations Excessive Commissioner for Refugees (UNHCR), Médecins Sans Frontières (MSF), and ReAct to determine supplementary proof, with an emphasis on figuring out case research and greatest practices for coverage concerns and interventions.
The occasion is open to everybody however is especially aimed toward excessive degree policymakers, together with ministries of well being, well being sector managers, tutorial establishments, and different key stakeholders.
The occasion will happen on Tuesday 6 September 2022 from 14:00 to fifteen:00 CEST (timezone adjuster).
- Dr Hanan Balkhy, Assistant Director-Common for Antimicrobial Resistance (AMR)
Chair – Rifat Hossain, Knowledge and proof, Well being and Migration Programme (PHM)
Strategic significance of International Proof evaluate on Well being and Migration (GEHM) for coverage making for refugees and migrants
- Dr Palmira Immordino, Knowledge and proof, PHM
Capturing the proof on entry to important antibiotics in migrant and refugee populations
- Dr Susan Rogers Van Katwyk, Managing Director, WHO Collaborating Centre on International Governance of Antimicrobial Resistance
Creating a “Folks-centred framework” for addressing Antimicrobial resistance (AMR)
- Mr Anand Balachandran, Unit Head, AMR, SPC – Nationwide Motion Plans and Monitoring
- Facilitated by Dr Enrique Castro-Sánchez, Affiliate Professor in An infection Prevention and Enchancment, Faculty of Nursing, Midwifery and Healthcare, College of West London
- Dr Santino Severoni, Director, PHM, WHO
- Dr Catharina Van Weezenbeek, Director, SPC/AMR